 | • レポートコード：MRC2303L120 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、238ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に1,081.9億ドルであった世界の薬用植物療法市場規模が2022年に1,162.5億ドルとなり、2027年までに年平均7.62％拡大して1,681.4億ドルに達すると予測されています。本書では、薬用植物療法の世界市場を対象に総合的に調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（薬用植物美容製品、薬用植物栄養補助食品、薬用植物機能食品、薬用植物医薬品）分析、形態別（カプセル＆錠剤、エキス、粉末、シロップ）分析、原料別（樹皮全草、果実、葉、根）分析、薬用植物種類別（ブラックコホシュ、アロエ、チャノキ、シナモン、ココヤシ）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの構成でまとめております。なお、本書に掲載されている企業情報には、Arizona Natural Products、ARKOPHARMA Laboratories Company Ltd.、Bayer AG、Beovita Vital GmbH、Bio-Botanica Inc.、Blackmores Limited、Blue Sky Botanics Ltd.、Dasherb Corp、Dr. Willmar Schwabe GmbH & Co. KG、Elzac Herbalsなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の薬用植物療法市場規模：製品別 - 薬用植物美容製品の市場規模 - 薬用植物栄養補助食品の市場規模 - 薬用植物機能食品の市場規模 - 薬用植物医薬品の市場規模 ・世界の薬用植物療法市場規模：形態別 - カプセル＆錠剤の市場規模 - エキスの市場規模 - 粉末の市場規模 - シロップの市場規模 ・世界の薬用植物療法市場規模：原料別 - 樹皮全草の市場規模 - 果実の市場規模 - 葉の市場規模 - 根の市場規模 ・世界の薬用植物療法市場規模：薬用植物種類別 - ブラックコホシュの市場規模 - アロエの市場規模 - チャノキの市場規模 - シナモンの市場規模 - ココヤシの市場規模 ・世界の薬用植物療法市場規模：地域別 - 南北アメリカの薬用植物療法市場規模 アメリカの薬用植物療法市場規模 カナダの薬用植物療法市場規模 ブラジルの薬用植物療法市場規模 ... - アジア太平洋の薬用植物療法市場規模 日本の薬用植物療法市場規模 中国の薬用植物療法市場規模 インドの薬用植物療法市場規模 韓国の薬用植物療法市場規模 台湾の薬用植物療法市場規模 ... - ヨーロッパ/中東/アフリカの薬用植物療法市場規模 イギリスの薬用植物療法市場規模 ドイツの薬用植物療法市場規模 フランスの薬用植物療法市場規模 ロシアの薬用植物療法市場規模 ... - その他地域の薬用植物療法市場規模 ・競争状況 ・企業情報 |
The Global Herbal Medicine Market size was estimated at USD 108.19 billion in 2021 and expected to reach USD 116.25 billion in 2022, and is projected to grow at a CAGR 7.62% to reach USD 168.14 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Herbal Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Herbal Beauty Product, Herbal Dietary Supplement, Herbal Functional Food, and Herbal Pharmaceutical.
Based on Form, the market was studied across Capsules & Tablets, Extracts, Powders, and Syrups.
Based on Source, the market was studied across Barks Whole Plant, Fruit, Leaves, and Roots.
Based on Type of Medicinal Plant, the market was studied across Actaea Racemosa, Aloe Vera, Camellia Sinensis, Cinnamomum Spp, Cocos Nucifera, Curcuma Longa, Echinacea, Marrubium Vulgare, Vaccinium Macrocarpon, and Zingiber Officinale.
Based on Indication, the market was studied across Blood Disorders, Digestive Disorders, and Respiratory Disorders.
Based on Distribution Channel, the market was studied across E-Commerce, Hospital & Retail Pharmacies, and Specialty Pharmaceutical Stores & Labs.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Herbal Medicine market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Herbal Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Herbal Medicine Market, including Arizona Natural Products, ARKOPHARMA Laboratories Company Ltd., Bayer AG, Beovita Vital GmbH, Bio-Botanica Inc., Blackmores Limited, Blue Sky Botanics Ltd., Dasherb Corp, Dr. Willmar Schwabe GmbH & Co. KG, Elzac Herbals, Frutarom Industries Ltd., Haldin Pacific Semesta, PT, Hishimo Pharmaceuticals Pvt. Ltd., Kalsec, Inc., Madaus GmbH, Prinova Group LLC., PT. Indesso Aroma, Ransom Naturals Ltd., Schaper & Brümmer GmbH & Co. KG, Synergy Flavors, Inc., Synthite Industries Ltd., TSUMURA & CO., Venus Pharma GmbH, Vopec Pharmaceuticals (P) Ltd., Weleda, and ZeinPharma Germany GmbH.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Herbal Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Herbal Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Herbal Medicine Market?
4. What is the competitive strategic window for opportunities in the Global Herbal Medicine Market?
5. What are the technology trends and regulatory frameworks in the Global Herbal Medicine Market?
6. What is the market share of the leading vendors in the Global Herbal Medicine Market?
7. What modes and strategic moves are considered suitable for entering the Global Herbal Medicine Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for natural medicines as an alternative to conventional medicine
5.1.1.2. Increasing research funding for herbal medicines
5.1.2. Restraints
5.1.2.1. Higher risk of allergies and other adverse effects through the use of herbal medicine
5.1.2.2. Consequent confusion and trust issue among consumers
5.1.3. Opportunities
5.1.3.1. Increasing awareness among consumers
5.1.3.2. Growth opportunities with well-established distribution channel
5.1.4. Challenges
5.1.4.1. Lack of standardization among global entities
5.2. Cumulative Impact of COVID-19
6. Herbal Medicine Market, by Product
6.1. Introduction
6.2. Herbal Beauty Product
6.3. Herbal Dietary Supplement
6.4. Herbal Functional Food
6.5. Herbal Pharmaceutical
7. Herbal Medicine Market, by Form
7.1. Introduction
7.2. Capsules & Tablets
7.3. Extracts
7.4. Powders
7.5. Syrups
8. Herbal Medicine Market, by Source
8.1. Introduction
8.2. Barks Whole Plant
8.3. Fruit
8.4. Leaves
8.5. Roots
9. Herbal Medicine Market, by Type of Medicinal Plant
9.1. Introduction
9.2. Actaea Racemosa
9.3. Aloe Vera
9.4. Camellia Sinensis
9.5. Cinnamomum Spp
9.6. Cocos Nucifera
9.7. Curcuma Longa
9.8. Echinacea
9.9. Marrubium Vulgare
9.10. Vaccinium Macrocarpon
9.11. Zingiber Officinale
10. Herbal Medicine Market, by Indication
10.1. Introduction
10.2. Blood Disorders
10.3. Digestive Disorders
10.4. Respiratory Disorders
11. Herbal Medicine Market, by Distribution Channel
11.1. Introduction
11.2. E-Commerce
11.3. Hospital & Retail Pharmacies
11.4. Specialty Pharmaceutical Stores & Labs
12. Americas Herbal Medicine Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Herbal Medicine Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Herbal Medicine Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Arizona Natural Products
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. ARKOPHARMA Laboratories Company Ltd.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Bayer AG
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Beovita Vital GmbH
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Bio-Botanica Inc.
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Blackmores Limited
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Blue Sky Botanics Ltd.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Dasherb Corp
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Dr. Willmar Schwabe GmbH & Co. KG
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Elzac Herbals
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Frutarom Industries Ltd.
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Haldin Pacific Semesta, PT
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Hishimo Pharmaceuticals Pvt. Ltd.
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Kalsec, Inc.
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Madaus GmbH
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Prinova Group LLC.
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. PT. Indesso Aroma
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Ransom Naturals Ltd.
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Schaper & Brümmer GmbH & Co. KG
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. Synergy Flavors, Inc.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
16.21. Synthite Industries Ltd.
16.21.1. Business Overview
16.21.2. Key Executives
16.21.3. Product & Services
16.22. TSUMURA & CO.
16.22.1. Business Overview
16.22.2. Key Executives
16.22.3. Product & Services
16.23. Venus Pharma GmbH
16.23.1. Business Overview
16.23.2. Key Executives
16.23.3. Product & Services
16.24. Vopec Pharmaceuticals (P) Ltd.
16.24.1. Business Overview
16.24.2. Key Executives
16.24.3. Product & Services
16.25. Weleda
16.25.1. Business Overview
16.25.2. Key Executives
16.25.3. Product & Services
16.26. ZeinPharma Germany GmbH
16.26.1. Business Overview
16.26.2. Key Executives
16.26.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing